Loading
Disc Medicine, Inc. Stock: price and insider trades · United States
US·Mcap US$2.5B
No insider purchase over the last 90 days. The latest was filed 20 Jun 2024.
Disc Medicine, Inc.: what insiders have been doing
Disc Medicine, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). 16 insiders have disclosed 105 filings since 18 October 2025.
Only sales appear on the open market, 55 sales in all totalling €66.9M, filed by 8 insiders. The amount is not disclosed for 12 filings. The largest single trade was a sale of €51.6M by AI DMI LLC, published on 24 October 2025.
The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Across the 5,458 companies tracked on its exchange, the median is 22 filings; at 105 filings, this issuer sits above that mark. Over the whole record (from 2021), the tally stands at 7 purchases and 99 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists net income at -212.2 m USD.
Elsewhere in the same market, our signals recently picked up insider purchases at GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
219
Thresholds
n/a
Buy Volume
€19M
7 ops. · all time
Sell Volume
€172M
99 ops. · all time
Who traded when
BuySaleKevin Bitterman26 sales
John D. Quisel12 sales
Yu Jonathan Yen-Wen10 sales
Savage William Jacob9 sales
Franchi Jean M.8 sales
Khara Rahul8 sales
+3 other insiders
Since the insiders bought
- +17.0%Entry US$44.18 · Close at T+365 US$51.68
- +17.0%Entry US$44.18 · Close at T+365 US$51.68
- +165.0%Entry US$25.06 · Close at T+365 US$66.42
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Disc Medicine, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$103.17.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$64.92
Analyst consensus
12 analystsStrong buy
US$83.00Target US$103.17(+59%)US$128.00
Income statement
EBITDA-US$207.9M
Net income-US$212.2M0.0% margin
Valuation
PER (forward)-9.2x
P/Book3.9x
Beta2.05
Balance sheet & cash
Market capUS$2.5B
Total debtUS$31M
Free Cash Flow-US$181.3M
Debt / Equity9%
Profitability & ownership
ROE-39.1%
ROA-24.0%
% insiders7.8%
% institutions114.1%
Last declaration on 16 September 2026
Declarations219 total
36,000 shares@ US$1.010.0014% mcap0.4% of flowCommon StockSEC:0001193125-26-393353:0
7,136 shares@ US$45.690.013% mcap0.8% of flowCommon StockSEC:0001591747-26-000007:0
10,000 shares@ US$38.850.015% mcap1.0% of flowCommon StockSEC:0001591747-26-000007:1
10,000 shares@ US$50.860.020% mcap1.3% of flowCommon StockSEC:0001591747-26-000007:2
27,136 shares@ US$70.110.073% mcap4.9% of flowCommon StockSEC:0001591747-26-000007:3
27,136 shares@ US$70.110.073% mcap100.0% of flowCommonSEC144:0001950047-26-009330
912 shares@ US$79.960.0028% mcap0.2% of flowCommon StockSEC:0001591747-26-000005:0
759 shares@ US$79.960.0023% mcap0.2% of flowCommon StockSEC:0001591747-26-000005:1
18 shares@ US$79.960.0001% mcap0.0% of flowCommon StockSEC:0001591747-26-000005:2
2,212 shares@ US$79.370.0068% mcap24.3% of flowCommon StockSEC144:0001628280-26-060745
18 shares@ US$79.370.0001% mcap24.8% of flowCommon StockSEC144:0001628280-26-060748
912 shares@ US$79.370.0028% mcap24.3% of flowCommon StockSEC144:0001628280-26-060746
759 shares@ US$79.370.0023% mcap24.3% of flowCommon StockSEC144:0001628280-26-060747
70 shares@ US$79.950.0002% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:0
58 shares@ US$79.950.0002% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:1
1 shares@ US$79.950.0000% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:2
26,542 shares@ US$80.170.082% mcap5.5% of flowCommon StockSEC:0001591747-26-000002:3
22,090 shares@ US$80.170.069% mcap4.6% of flowCommon StockSEC:0001591747-26-000002:4
511 shares@ US$80.170.0016% mcap0.1% of flowCommon StockSEC:0001591747-26-000002:5
10 shares@ US$80.980.0000% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:6
9 shares@ US$80.980.0000% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:7
2 shares@ US$80.980.0000% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:8
2,810 shares@ US$79.980.0087% mcap0.6% of flowCommon StockSEC:0001591747-26-000002:9
2,339 shares@ US$79.980.0072% mcap0.5% of flowCommon StockSEC:0001591747-26-000002:10
54 shares@ US$79.980.0002% mcap0.0% of flowCommon StockSEC:0001591747-26-000002:11
25 of 219 declarations
About Disc Medicine, Inc.
Disc Medicine, Inc. is a biopharmaceutical company focused on developing innovative treatments for blood disorders. It is listed on NASDAQ under the ticker symbol IRON.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
